Richard Price: Advancing Treatment and Care in Metastatic Cancer
Richard Price/LinkedIn

Richard Price: Advancing Treatment and Care in Metastatic Cancer

Richard Price, Policy Director at European Cancer Organisation, shared a post on LinkedIn:

“The number of people living with metastatic cancer is increasing – a testament to advances in treatment and care.

Yet metastatic cancer brings a distinct set of challenges that health systems are still not fully equipped to address. From clinical communication to long-term social and legal implications, there is an urgent need to adapt our approaches.

There are solutions – and this is where the conversation matters.

Join us this coming Tuesday afternoon for a global expert roundtable exploring:

  • The prevalence and patient experience of brain metastases.
  • How clinicians communicate a metastatic diagnosis – and why this must evolve.
  • The social and legal realities of living with metastatic cancer.

This promises to be an insightful and thought-provoking discussion, bringing together perspectives from across disciplines and geographies.

We look forward to your participation and contributions to the conversation.

Register before Tuesday.”

Other articles featuring Richard Price on OncoDaily.